Mayo Clinic Q&A: COVID-19 news update

Host: Darryl S. Chutka, M.D. Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B. The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they’re frequently taken for the weight loss ...  Show more

Host: Darryl S. Chutka, M.D. Guest: Tamim Rajjo, M.D., M.P.H. Using GLP-1 medication for weight loss has become very popular with our patients. In the recent past, this has produced a shortage of these medications available, and those taking them for management of diabetes have f ...  Show more

Last week, researchers at the Los Alamos National Laboratory released alarming news: At least one variant of the virus that causes Covid-19 had significantly mutated to become more contagious. If true, this would have major implications. A new variant could, for example, hamper e ...  Show more

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Rec ...

How reliable are at-home COVID-19 tests? Are there shortcomings to “testing out” of vaccine mandates? IDSA members Dial Hewlett, MD, FIDSA of the Westchester County Health Department and Nira Pollock, MD, FIDSA of Boston Children’s Hospital join us to discuss the latest on COVID- ...  Show more

HIV stellt uns auch heute noch vor große Herausforderungen in der Versorgung. Wann müssen wir an einen Test denken? Und gibt es eine Chance auf Heilung?